| Literature DB >> 1519267 |
Abstract
I recount my involvement in the development of biologically active, totally synthetic steroid hormones since 1941. The reasons for my approach to the first total synthesis of a potent androgen are given. I touch on the even more important general synthetic outcomes from ideas generated by the search for useful amounts of a cortically active hormone, such as novel angular methylations, partial hydrogenations of aromatic systems (Birch reductions), and novel usages in synthesis based on the unique structures so generated. The Birch process was critical for synthesis of the first oral contraceptives. A need to explain the structures of Birch reduction products and the experimental requirements resulted in further elucidations of the mechanism of reduction processes, notably for aromatic compounds. The first theoretical and practical distinction between structures of products as determined by a reaction rate or an equilibrium position was first exploited experimentally in the deconjugation of cholest-4-en-3-one in the final step of the first facile total synthesis of cholesterol. A knowledge gained of the biosynthesis of steroids and its specific enzymes helped to initiate my general polyketide theory of biosynthesis and also my idea of outdoing enzyme achievements with organometallic complexes ("inorganic enzyme chemistry"). I assert the high historic importance of steroids in promoting the advance of general organic chemistry within many fields.Entities:
Keywords: Adrenal Cortex Hormones; Androgens; Biology; Contraception; Contraception Research; Contraceptive Methods; Economic Factors; Endocrine System; Examinations And Diagnoses; Family Planning; Historical Survey; Hormones; Ingredients And Chemicals; Laboratory Examinations And Diagnoses; Laboratory Procedures; Oral Contraceptives; Organic Chemicals; Physiology; Progestational Hormones; Research And Development; Research Methodology; Technology
Mesh:
Substances:
Year: 1992 PMID: 1519267 DOI: 10.1016/0039-128x(92)90080-s
Source DB: PubMed Journal: Steroids ISSN: 0039-128X Impact factor: 2.668